Kevin Camphausen

National Cancer Institute, National Institutes of Health

Papers

Total Citations

117

H-Index

About

Kevin Camphausen is a leading figure in the development of MRI-guided robotic systems for prostate cancer diagnosis and intervention. His primary research focuses on the intersection of medical robotics, interventional MRI, and urologic oncology, with a specific emphasis on overcoming the technical challenges of precise needle placement within the magnetic resonance environment. His most impactful contribution is the design and clinical validation of the Access to the Prostate Tissue (APT) II system, a scanner-independent robotic platform for MRI-guided transrectal prostate interventions. This work, detailed in his highly cited 2011 paper (99 citations), represents a significant leap forward by demonstrating a clinically viable, hybrid-tracking system that improves targeting accuracy. Camphausen has also made critical contributions to understanding and mitigating imaging artifacts, as shown in his 2012 study (18 citations) on biopsy needle localization, which is essential for confirming accurate needle placement during procedures. Through this pioneering work, Camphausen has helped lay the foundation for more precise, minimally invasive prostate cancer care, directly impacting the field of image-guided therapy.